Efficacy and safety of obinutuzumab in primary membranous nephropathy: a real-world retrospective study

Efficacy and safety of obinutuzumab in primary membranous nephropathy: a real-world retrospective study

ObjectiveThis study aimed to evaluate the efficacy and safety of obinutuzumab, a novel anti-CD20 monoclonal antibody, in patients with primary membranous nephropathy (pMN).MethodsFifty-five patients with pMN treated with obinutuzumab were respectively enrolled in this study. Clinical and immunologic...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xi Cheng, Zhen-feng Zheng, Yan Qi, Xin Cao, Xi-qian Gao, Ying-xin Fang, Li Wei, Wen-ya Shang, Tie-kun Yan, Jun-ya Jia, Peng-cheng Xu, Qiu-hua Gu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Immunology
Subjects:	membranous nephropathy obinutuzumab rituximab anti-phospholipase A2 receptor antibody renal function
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1650054/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Obinutuzumab as Initial or Second-Line Therapy in Patients With Primary Membranous Nephropathy
by: Xiaole Su, et al.
Published: (2024-08-01)

Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies
by: Maxime Teisseyre, et al.
Published: (2025-03-01)

Study on predictors for treatment efficacy of rituximab in patients with PLA2R-negative primary membranous nephropathy
by: XU Lili, HU Xiaofan, LI Hao, WANG Weiming
Published: (2025-06-01)

Clinicopathological characteristics of idiopathic membranous nephropathy in 65 elderly patients
by: LIU Wen-xue, et al.
Published: (2017-01-01)

Research progresson correlation of PLA2R1 and HLA gene polymorphisms with susceptibility toidiopathic membranous nephropathy
by: XIE Da-xing, et al.
Published: (2019-01-01)

PLA2R-associated membranous nephropathy associated with renal clear cell carcinoma: one case report
by: Xu Xiao-chang, et al.
Published: (2021-01-01)

Recent progress in the pathogenesis of membranous nephropathy
by: He Zhi-hua, et al.
Published: (2022-05-01)

Efficacy and safety of rituximab for membranous nephropathy in adults: a meta-analysis of RCT
by: Baike Mao, et al.
Published: (2025-04-01)

The efficacy and safety of ripertamab in the treatment of idiopathic membranous nephropathy: a retrospective multicenter cohort study
by: Xinyang Li, et al.
Published: (2025-07-01)

Expression and significance of phospholipase A2 receptor and thrombospondin type-1 domain 7A in idiopathic membranous nephropathy
by: LI Fei, et al.
Published: (2019-01-01)

Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy
by: Brad H. Rovin, et al.
Published: (2024-09-01)

Clinical Characteristics and Outcomes of Neural Epidermal Growth Factor-like 1 Protein-Associated Membranous Nephropathy
by: Suruthy Narayanasami, et al.
Published: (2024-05-01)

Obinutuzumab-induced severe acute thrombocytopenia: a case report and literature review
by: Kun Kou, et al.
Published: (2025-08-01)

Venetoclax-Based Regimens in CLL: Immunoglobulin G Levels, Absolute Neutrophil Counts, and Infectious Complications
by: Wojciech Szlasa, et al.
Published: (2025-06-01)

Combination Therapy With Rituximab and Low-Dose Cyclophosphamide and Prednisone in Membranous Nephropathy
by: Coralien H. Vink, et al.
Published: (2024-12-01)

Rituximab in the treatment of refractory nephrotic syndrome with massive pleural effusion: one case report
by: Zhang Shuo-fan, et al.
Published: (2021-01-01)

Clinical efficacy of tacrolimus combined with glucocorticoids for idiopathic membranous nephropathy
by: LING Yi-sheng, et al.
Published: (2016-01-01)

Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy
by: Jinxiu Liang, et al.
Published: (2023-12-01)

The essential role of electron microscopy in the diagnosis of collagen type III glomerulopathy superimposed with membranous nephropathy or diabetic nephropathy
by: Fangcheng Zhang, et al.
Published: (2025-07-01)

Differences in serum anti-PLA2R antibody determination in Uygur patients with idiopathic membranous nephropathy in Xinjiang
by: ZHANG Jin, et al.
Published: (2018-01-01)

Obinutuzumab combined with bendamustine for the treatment of hairy cell leukemia variant: a case report and literature review
by: Junjun Bai, et al.
Published: (2025-08-01)

Efficacy of tacrolimus or cyclophosphamide combined with glucocorticoids in the treatment of idiopathic membranous nephropathy
by: MAO Wen-li, et al.
Published: (2018-01-01)

Membranous nephropathy with eosinophilic gastroenteritis and protein-losing enteropathy： a case report and literature review
by: Ke Jia-er, et al.
Published: (2025-01-01)

Applications of rituximab in the treatment of renal diseases
by: Liu Zi, et al.
Published: (2021-01-01)

A retrospective study of calcineurin inhibitors in the treatment of idiopathic membranous nephropathy
by: CUI Lin-lin, et al.
Published: (2015-01-01)

Research advances of idiopathic membranous nephropathy with non-nephrotic range proteinuria
by: Sun Jing, et al.
Published: (2022-10-01)

Association of serum homocysteine levels with acute kidney injury in patients with idiopathic membranous nephropathy
by: XIE Yi-yi, et al.
Published: (2018-01-01)

A controlled clinical study of efficacy of different treatment regimens for idiopathic membranous nephropathy
by: LUO Man-yu, et al.
Published: (2019-01-01)

Early caplacizumab and obinutuzumab enable successful treatment of relapsing thrombotic thrombocytopenic purpura without therapeutic plasma exchange: a case report
by: Judith Schimpf, et al.
Published: (2025-04-01)

Case Report: Membranous nephropathy associated with mantle cell lymphoma: a rare case
by: Mian Ren, et al.
Published: (2025-08-01)

Idiopathic membranous nephropathy with focal segmental sclerosis
by: Elena S. Kamyshova, et al.
Published: (2024-01-01)

Clear cell renal cell carcinoma complicated with PLA2R-associated membranous nephropathy：three cases report and literature review
by: Sun Miao-xin, et al.
Published: (2025-02-01)

Recent advances in diagnosis and treatment of primary membranous nephropathy
by: HU Xiaofan, XU Jing
Published: (2025-06-01)

Metastatic neuroendocrine carcinoma in inguinal region complicated with membranous nephropathy: a case report
by: Xinyun Qiang, et al.
Published: (2025-07-01)

Analysis of influencing factors for primary membranous nephropathy complicated with atherosclerotic cardiovascular disease and establishment of a nomogram prediction model
by: Mirixiatijiang· Maimaiti, et al.
Published: (2025-03-01)

Monoclonal anti-CD20 antibodies in lymphomas therapy during the COVID-19 pandemic: pro and contra
by: K. A. Sychevskaya, et al.
Published: (2022-04-01)

Angiopoietin-like4 can be used to evaluate and predict efficacy for membranous nephropathy
by: WANG Jian, et al.
Published: (2019-01-01)

Clinicopathologic classification of diabetic nephropathy and expression of Ang-2 in renal tissues
by: WEIZhi-min, et al.
Published: (2016-01-01)

Concurrent IgG4-related membranous nephropathy and proliferative diabetic kidney disease: a diagnostic dilemma and therapeutic strategy in long-standing diabetes
by: Yue Yang, et al.
Published: (2025-07-01)

Trans-ethnic Mendelian randomization analysis of membranous nephropathy and peripheral artery disease with mediating effects of thrombomodulin
by: Juhong Pan, et al.
Published: (2025-05-01)